GOLDMAN SACHS GROUP INC - 31 Mar 2025 SCHEDULE 13G/A Report for SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0001 per share (SLXN)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0001 per share
Symbol: SLXN
Shares outstanding: 8,831,042 shares
Disclosed Ownership: 211,945 shares
Ownership: 2.4%
Form type: SCHEDULE 13G/A
Filing time: 13 May 2025, 11:36:32 UTC
Date of event: 31 Mar 2025
Previous filing: 10 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	2.4%	211,945	0	211,945	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	2.4%	211,945	0	211,945	Name: Sam Prashanth	Attorney-in-fact